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Abstract Adenosine increases coronary flow mainly through
the activation of A2A and A2B adenosine receptors (ARs).
However, the mechanisms for the regulation of coronary flow
are not fully understood. We previously demonstrated that
adenosine-induced increase in coronary flow is in part through
NADPH oxidase (Nox) activation, which is independent of
activation of either A1 or A3ARs. In this study, we hypothesize
that adenosine-mediated increase in coronary flow through
Nox activation depends on A2A but not A2BARs. Functional
studies were conducted using isolated Langendorff-perfused
mouse hearts. Hydrogen peroxide (H2O2) production was
measured in isolated coronary arteries from WT, A2AAR
kno c k ou t (KO ) , a n d A 2 BAR KO m i c e u s i n g
dichlorofluorescein immunofluorescence. Adenosine-
induced concentration-dependent increase in coronary flow
was attenuated by the specific Nox2 inhibitor gp91 ds-tat or
reactive oxygen species (ROS) scavenger EUK134 in both
WT and A2B but not A2AAR KO isolated hearts. Similarly,
the A2AAR selective agonist CGS-21680-induced increase in
coronary flow was significantly blunted by Nox2 inhibition in
both WT and A2BAR KO, while the A2BAR selective agonist
BAY 60-6583-induced increase in coronary flow was not af-
fected by Nox2 inhibition in WT. In intact isolated coronary
arteries, adenosine-induced (10 μM) increase in H2O2 forma-
tion in bothWTandA2BARKOmice was attenuated byNox2
inhibition, whereas adenosine failed to increase H2O2 produc-
tion in A2AAR KO mice. In conclusion, adenosine-induced
increase in coronary flow is partially mediated by Nox2-
derived H2O2, which critically depends upon the presence of
A2AAR.
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Introduction
Coronary flow is tightly regulated to maintain a consis-
tently high level of myocardial oxygen extraction over a
wide range of myocardial demands [1–3]. This tight reg-
ulation is dependent on numerous vasoconstrictor and va-
sodilator influences, exerted by the autonomic nervous
system, endothelium, and myocardium [3–6]. Adenosine,
a well-known locally released metabolite, has been postu-
lated as one of the important agents responsible for coro-
nary vascular tone regulation in various conditions [3, 5,
7–9], among which adenosine has also been thought to
regulate resting coronary flow [10, 11]. However, the role
of adenosine in regulating resting coronary flow remains
controversial [3]. This discrepancy may be due to differ-
ent animal models, differences in species, and/or different
agonists and antagonists used in these studies. It is well
established that the coronary effects of adenosine are me-
diated through the activation of its four subtypes of recep-
tors, namely A1, A2A, A2B, and A3 receptors (ARs) [9, 12,
13]. The role of these receptors has been studied in
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various species [12]. With an overall coronary vasodila-
tion, A2AAR predominantly and A2BAR minimally con-
tribute to dilating coronary vasculature [14–16], whereas
A1AR and A3AR counteract the effects of A2A/A2BARs
resulting in a diminished coronary vasodilation [15, 17,
18]. At post-receptor levels, several effector pathways of
adenosine-mediated coronary flow have been reported,
such as activation of nitric oxide (NO) pathway [19, 20],
cyclic adenosine 5′-monophosphate (cAMP)-dependent
pathway [21], activation of potassium channels [9, 21],
and the involvement of H2O2 [19]. However, the down-
stream effectors linked to the activation of ARs in this
process are not completely understood.
H2O2, a molecule within the reactive oxygen species
(ROS) family, has been proposed to serve as a pivotal vasodi-
lator in coronary flow regulation in human, canine, porcine,
and murine coronary vasculature [19, 22–26]. NADPH oxi-
dases (Nox) are the major source of ROS in the vasculature
that plays both physiological and pathophysiological roles in
the control of vascular tone [27–29]. The Nox family consists
of seven members, Nox1-5, Doux1, and Doux2, among which
Nox2 (gp91 Phox) forms the major source of H2O2 in cells
stimulated with growth factors or cytokines under normal cir-
cumstances [30, 31]. Indeed, in the coronary vasculature,
Nox2 has been proposed to be a functionally relevant source
of H2O2 that mediates agonist-induced vasodilation [32].
Several recent studies have shown the interaction between
adenosine and ROS via the regulation of Nox activity. For
instance, inhibition or deletion of Nox2 leads to the attenua-
tion of adenosine vasoconstrictor responses in aortas [33] and
renal arterioles [34] and adenosine vasodilator responses in
cerebral arteries [35]. However, little is known about the in-
volvement of Nox2-derived ROS in adenosine-mediated flow
response in the coronary circulation. Although activation of
A1 and A3AR has been shown to have vascular effects
through ROS [33, 36], our recent studies have already exclud-
ed the involvement of A1 and A3ARs in ROS-mediated regu-
lation of coronary flow [37]. Therefore, with the focus on the
adenosine signaling, the first aim of the present study was
to further investigate whether A2A and/or A2BAR are in-
volved in Nox2-derived ROS-mediated coronary vasodila-
tion. Given the previous findings that adenosine A2AAR
coupled to H2O2 contributes to coronary reactive hyper-
emia [38] and Nox2 acts as a functional source for H2O2
resulting in coronary vasodilation [32], the second aim of
the present study was to examine whether Nox2-derived
ROS production contributing to adenosine-mediated coro-
nary flow is through H2O2 and which adenosine receptors
are required in this process. We performed exogenous in-
fusion of adenosine in Langendorff-perfused isolated
hearts as well as immunohistochemistry in isolated coro-
nary arteries from wild type (WT), A2AAR knockout (KO),
and A2BAR KO mice for these studies.
Methods
Materials
EUK134 was purchased from Cayman Chemical (Ann Arbor,
MI, USA), gp91 ds-tat was purchased from Anaspec
(Fremont, CA, USA), and BAY 60-6583 was obtained as a
gift from Bayer AG (Leverkusen, Germany). All other
chemicals (adenosine, CGS-21680 and 2′,7′-dichloro-fluores-
cein diacetate (DCFH-DA)) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Stock solutions of adenosine,
BAY 60-6583, CGS-21680, EUK134, and DCFH-DA were
made in dimethyl sulfoxide (DMSO), whereas gp91 ds-tat
was dissolved in distilled water.
Animals
All experimental protocols were approved by the Institutional
Animal Care and Use Committee at West Virginia University
School of Medicine. We followed guidelines set forth by
National Institutes of Health regarding the care and use of
laboratory animals. WT mice (C57BL/6 background) were
purchased from The Jackson Laboratory (Bar Harbor, ME,
USA). A2A and A2BAR KO mice on an inbred C57BL/6
background were generously provided by Dr. Catherine
Ledent (Universite Libre de Bruxelles, Belgium) and Dr.
Stephen Tilley (University of North Carolina, Chapel Hill,
NC, USA), respectively. Mice were kept in cages with
12:12-h light-dark cycles and maintained on a standard labo-
ratory diet with access to water ad libitum. The absence of A2A
and A2BARs at mRNA level in A2AAR KO and A2BAR KO
mice has been confirmed by our previous studies using PCR
in isolated aortas, mesenteric arteries, and coronary arteries
[16, 20, 39–41]. With difficulties in collecting large amount
of tissues for Western blot, one of our recent studies has con-
firmed the absence of A2AAR protein level in A2AAR KO
mice in isolated coronary arteries using immunohistochemis-
try [40]. Our functional data also confirmed the lack of CGS-
21680 (a selective A2AAR agonist)-induced coronary flow
response in isolated hearts of A2AAR KO mice and the lack
of BAY 60-6583 (a selective A2B AR agonist)-induced coro-
nary flow response in isolated hearts of A2BAR KOmice [16,
20].
Langendorff-perfused mouse heart preparation
Mice (14–18 weeks) of either sex were anesthetized with
pentobarbital sodium (50 mg kg−1, i.p.). Mice were
weighed before hearts were rapidly removed into heparin-
ized (5 U ml−1) ice-cold Krebs-Henseleit buffer contain-
ing (in mM) 119 NaCl, 11 glucose, 22 NaHCO3, 4.7 KCl,
1.2 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 2 pyruvate, and 0.5
EDTA. After removal of the surrounding tissue, the aorta
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was rapidly cannulated with a 20-gauge, blunt-ended nee-
dle; then, the heart was continuously perfused with 37 °C
buffer bubbled with 95 % O2/5 % CO2 at a constant per-
fusion pressure of 80 mmHg [20, 40]. Subsequently,
through an opening in the left atrium, a fluid-filled bal-
loon made of plastic wrap was inserted into the left ven-
tricle across the mitral valve. The balloon was connected
to a pressure transducer for continuous measurement of
left ventricular developed pressure (LVDP) and heart rate.
The heart was then immersed in a water-jacketed perfus-
ate bath maintained at 37 °C and beats spontaneously.
Coronary flow was continuously measured with an ultra-
sonic flow probe (Transonic Systems, Ithaca, NY, USA)
placed in the aortic perfusion line. A PowerLab Chart data
acquisition system (AD Instruments, Colorado Springs,
CO, USA) was used for data acquisition. Hearts were
allowed to equilibrate for 30 to 45 min before starting
experimental protocols. Hearts with persistent arrhythmias
were excluded from the study. As a positive control, a 15-
s flow occlusion resulted in a twofold increase in coronary
flow over baseline [19, 38], indicating that buffer-
perfused hearts have minimum hypoxia and coronary ves-
sels have the capacity to further dilate.
Langendorff experimental protocols
After equilibrium, baseline coronary flow, heart rate (HR),
and LVDP were measured. Adenosine concentration re-
sponse curves (10−8–10−5 M) were acquired in perfused
hearts from WT, A2AAR KO, and A2BAR KO mice. Each
concentration of adenosine was infused for 5 min follow-
ed by a minimum of 5 min of perfusion for drug washout
[16, 37]. In separate experiments, the specific Nox2 in-
hibitor gp91 ds-tat (1 μM) [42] or the superoxide dismut-
ase and catalase-mimicking drug EUK134 (50 μM) was
perfused for 20 min before acquiring adenosine concen-
tration response curves (10−8–10−5 M) in perfused hearts
from those mice [37].
In another two experimental groups, the selective A2AAR
agonist CGS-21680 concentration response curves (10−10–
10−6 M) were acquired in perfused hearts from WT, A2AAR
KO, and A2BAR KOmice, while the selective A2BAR agonist
BAY 60-658 concentration response curves (10−10–10−6 M)
were acquired in perfused hearts only from WT mice. In sep-
arate experiments, the specific Nox2 inhibitor gp91 ds-tat
(1 μM) was perfused for 20 min before acquiring CGS-
21680 and BAY 60-658 concentration response curves
(10−10–10−6 M), respectively [16, 37]. All compounds were
infused at a rate of 1/100 ml min−1 of the coronary flow
through an injection port directly proximal to the aortic can-
nula using a microinjection pump (Harvard Apparatus,
Holliston, MA, USA) [16, 20, 37].
Fluorescence detection of H2O2 in mouse coronary
arteries
Left coronary arteries (with diameter of 50–120 μm) were
isolated from WT, A2AAR KO, and A2BAR KO mice. Then,
coronary arteries were incubated in DCFH-DA (10 μM) pre-
pared in DMEM (ATCC, Manassas, VA, USA) for 30 min at
37 °C followed by 10-min wash [40]. Vessels were then
pinned on a layer of silicone gel lying on a plastic culture dish
and incubated with DMEM buffer maintained at 37 °C.
Baseline control images were obtained by optical xyz section-
ing with a vertical depth of 1 μm using a Zeiss water immer-
sion objective (W N-AchroplanX40/0.75 numerical aperture)
on a confocal microscope (LSM 510, Zeiss, Heidelberg,
Germany). Once the baseline control images were acquired,
adenosine (10μM)was added into the culture dish and images
were taken at 5 min (in some vessels at both 5 and 10 min)
after adenosine incubation. We previously showed that a max-
imal fluorescence intensity of DCFH-DA was reached after
15 min of adenosine incubation [40], and there was no differ-
ence in fluorescence intensity between 5 and 10 min in the
present study (data not shown). The data at 5 min after aden-
osine incubation was used for analysis. In separate sets of
experiments, the arteries were treated with the Nox2 inhibitor
gp91 ds-tat (1 μM) for 20 min and baseline control images
were obtained before the addition of adenosine. After 5 min of
adenosine incubation, additional images were taken.
Hydrogen peroxide (200 μM) served as the positive control
at the end of experiments [37, 40]. Only the bottom half of
vessels (more proximal to the scanner) were scanned by xyz
sectioning, in order to avoid the quenching as much as possi-
ble. ImageJ software was used for fluorescence image analy-
sis. Stacks of regions of interest (ROIs) were selected on the
basis of the outline of the vessel indicated by the fluorescence.
Statistical analysis
Langendorff baseline data for WT, A2AAR KO, and A2BAR
KO groups were compared using one-way ANOVA followed
by post hoc analysis using Bonferroni’s test. The effects of
drug treatment on concentration response curves of adenosine,
CGS-21680, and BAY 60-6583 were analyzed using two-way
ANOVA followed by post hoc analysis using Bonferroni’s
test. Since the absolute coronary flow changes proportionally
with heart mass, the coronary flow was presented as
ml min−1 g−1 wet heart weight [16, 37, 43]. With regard to
imaging, the mean fluorescence intensity of each ROI (includ-
ing those on both endothelial cells and smooth muscle cells)
was calculated by subtraction of the background signal and
changes in fluorescence intensity were presented as a ratio
normalized to control [40]. Image data were analyzed using
paired t test. All the data are presented as mean±SEM; n
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represents the number of animals. Statistical significance was
accepted when P<0.05.
Results
Baseline function in isolatedWT, A2AARKO, and A2BAR
KO mouse hearts
Table 1 summarizes the baseline functional parameters for
heart rate, LVDP, and coronary flow in WT, A2AAR KO,
and A2BAR KO mice after 30 min of equilibration of isolated
hearts. Average heart weight to body weight ratio was signif-
icantly different between A2AAR KO and A2BAR KO mice,
which is due to a heavier body weight in A2BAR KO mice as
compared to A2AAR KOmice (27±0.7 g in A2BAR KOmice
vs. 24±0.5 g in A2AAR KO mice), while the heart weight
between the groups was comparable. However, no significant
differences were observed in heart rate, LVDP, and baseline
coronary flow from those mice (P>0.05, by one-way
ANOVA) (Table 1).
Effects of Nox2 inhibition and A2AAR/A2BAR deletion
on adenosine-induced increase in coronary flow
Adenosine produced a concentration-dependent increase in
coronary flow in WT mice (Emax: 38.13±0.78 ml min
−1 g−1,
data obtained from both Figs. 1a and 2a), which was signifi-
cantly attenuated by Nox2 inhibition with gp91 ds-tat
(Fig. 1a). In agreement with our previous studies [37], these
findings indicate that adenosine-induced increase in coronary
flow in WT mice is mediated in part through Nox2 activation.
Notably, inhibition of Nox2 by gp91 ds-tat in A2AAR KO
mice had no effect on adenosine-induced increase in coronary








Age, week 16±0.3 15±0.3 16±0.4
No. of mice 21 15 17
BW, g 25±0.8 24±0.5 27±0.7
HW, mg 96.2±2.6 99.1±2.6 98.4±2.4
HW/BW, % 0.39±0.01 0.42±0.01 0.37±0.02*
CF, ml min−1 g−1 18±0.6 18±0.9 20±0.4
HR, beats min−1 437±10 391±8 446±10
LVDP, mmHg 90±4 90±5 80±4
All parameters were collected after 30 min of equilibration in a
Langendorff preparation. Values are means±SEM
WTwild type,KO knockout mice,BW bodyweight,HW heart weight,CF
coronary flow, HR heart rate, LVDP left ventricular developed pressure





















































































Fig. 1 Effects of NADPH oxidase (Nox2) inhibition on adenosine-
induced increase in coronary flow. Shown are the effects of gp91 ds-tat
(1 μM) on adenosine (Ado) concentration response curves (10−8 to
10−5 M) in isolated hearts of wild type (WT) (a, n=6), A2A receptor
(AR) knockout (KO) (b, n=6), and A2BAR KO mice (c, n=6). Values
are mean±SEM. *Significant difference vs. corresponding control points
using two-wayANOVA followed by post hoc analysis using Bonferroni’s
test (P<0.05)
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flow (Fig. 1b) but significantly attenuated the increased coro-
nary flow in A2BAR KO mice (Fig. 1c). All together, these
findings indicate that adenosine-induced increase in coronary
flow is partially mediated via activation of Nox2 and likely
depends on A2A but not A2BARs.
Effects of ROS scavenging and A2A/A2BAR deletion
on adenosine-induced increase in coronary flow
In accordance with previous studies from our laboratory [37],
ROS scavenging with EUK134 markedly attenuated the
adenosine-induced increase in coronary flow in WT mice
(Fig. 2a). Similar to the effects of Nox2 inhibition, ROS scav-
enging with EUK134 had no effect on adenosine-induced in-
crease in coronary flow in A2AAR KO mice (Fig. 2b) but
significantly attenuated the increased coronary flow in
A2BAR KO mice (Fig. 2c). All together, these findings indi-
cate that ROS production is involved in adenosine-induced
increase in coronary flow, which depends on A2A but not
A2BAR activation.
Effects of Nox2 inhibition and A2AAR/A2BAR deletion
on A2AAR/A2BAR agonist-mediated increase in coronary
flow
To further investigate the role of A2AAR in this process, the
selective A2AAR agonist CGS-21680 concentration response
curves were acquired. CGS-21680 produced a concentration-
dependent increase in coronary flow in WT, which was sig-
nificantly blunted by Nox2 inhibition with gp91 ds-tat
(Fig. 3a). A similar finding was also observed in A2BAR KO
mice in which CGS-21680-induced increase in coronary flow
was significantly attenuated by the Nox2 inhibitor gp91 ds-tat
(Fig. 3c). As expected, CGS-21680 failed to increase coronary
flow in A2AAR KO mice (Fig. 3b). To further exclude the
involvement of A2BAR, the selective A2BAR agonist BAY
60-6583 concentration response curves were acquired in WT
mice. BAY 60-6583 produced a concentration-dependent in-
crease in coronary flow, which was not affected by the Nox2
inhibitor gp91 ds-tat (Fig. 4). Taken together, these findings
indicate that adenosine-induced increase in coronary flow is
partially mediated by Nox2-derived ROS, which requires
A2AARs.
Effects of Nox2 inhibition and A2AAR/A2BAR deletion
on H2O2 production by adenosine in isolated coronary
arteries
To assess the potential involvement of vasodilator ROS
(H2O2) in adenosine-induced increase in coronary flow,
DCFH-DA immunofluorescence was performed on intact iso-
lated coronary arteries. As shown in Fig. 5, adenosine
(10 μM) increased H2O2 generation in both WT and A2BAR
KO mice (Fig. 5a), as evidenced by increases in fluorescence
intensity ratio in adenosine-treated tissues (1.36±0.04 and





































































































Fig. 2 Effects of ROS scavenging on adenosine-induced increase in
coronary flow. Shown are the effects of EUK134 (50 μM) on adenosine
(Ado) concentration response curves (10−8 to 10−5M) in isolated hearts of
WT (a, n=5), A2AAR KO (b, n=4), and A2BAR KO mice (c, n=6).
Values are mean±SEM. *Significant difference vs. corresponding
control points using two-way ANOVA followed by post hoc analysis
using Bonferroni’s test (P<0.05)
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P<0.05) as compared to corresponding baseline (Fig. 5b).
H2O2 production was observed in both endothelial cells
(ECs, arrow head) as well as smooth muscle cells (SMCs,
arrow) (Fig. 1a). Of note, adenosine-increased H2O2
production was inhibited by the Nox2 inhibitor gp91 ds-tat
in both WT and A2BAR KO mice to baseline levels (Fig. 5a,
b). More importantly, adenosine failed to increase H2O2 pro-
duction from A2AAR KO mice either in the presence or ab-
sence of Nox2 inhibition (Fig. 5a, b). Hydrogen peroxide
(200 μM) added at the end of experiments further increased
fluorescence (Fig. 5a), indicating that the dye did not reach the
saturation point [40]. Taken together, these data further sug-
gest that Nox2 is an important source for H2O2 production,
which depends on the activation of A2AARs by adenosine.
Discussion
This study examined the hypothesis that A2A and/or A2BAR-
mediated coronary vasodilation involves Nox2-derived ROS.
With the focus on the adenosine signaling pathway, we mea-
sured changes in coronary flow in isolated hearts from WT,
A2AAR, and A2B AR KOmice in response to Nox2 inhibition
(gp91 ds-tat) or ROS scavenging (EUK134) during exoge-
nous adenosine infusion. In addition, the downstream effector
(H2O2) of ROS in this process was also assessed in isolated
coronary arteries from WT, A2AAR, and A2B AR KO mice.
The main findings of the present study are as follows: (1)
either Nox2 inhibition with gp91 ds-tat or ROS scavenging
with EUK134 attenuated the adenosine-induced increase in
coronary flow in WT and A2BAR KO mice but not in
A2AAR KO mice; (2) Nox2 inhibition blunted the A2AAR
agonist-increased coronary flow inWTand A2BAR KOmice,
whereas the A2BAR agonist responses were unaltered by
Nox2 inhibition in WT mice; (3) furthermore, adenosine-
mediated increase in H2O2 formation in intact isolated coro-
nary arteries of WT and A2BAR KO mice was inhibited by


































































































Fig. 3 Effects of Nox2 inhibition on adenosine A2AAR agonist-induced
increase in coronary flow. Shown are the effects of gp91 ds-tat (1 μM) on
CGS-21680 (CGS, the A2AAR selective agonist) concentration response
curves (10−10 to 10−6 M) in isolated hearts of WT (a, n=6), A2AAR KO
(b, n=5), and A2BAR KO mice (c, n=5). Values are mean±SEM.
*Significant difference vs. corresponding control points using two-way






























Fig. 4 Effects of Nox2 inhibition on adenosine A2BAR agonist-induced
increase in coronary flow. Shown are the effects of gp91 ds-tat (1 μM) on
BAY 60-6583 (BAY, the A2BAR selective agonist) concentration
response curves (10−10 to 10−6 M) in isolated hearts of WT mice (n=4).
Values are mean±SEM
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by adenosine either with or without Nox2 inhibition in
A2AAR KO mice. The implications of these findings are
discussed below.
Adenosine-induced increase in coronary flow is mediated
in part through Nox2-derived ROS
Adenosine is known to regulate coronary vascular tone in
various species.We [20, 44] and others [10, 11, 45] previously
demonstrated that adenosine also plays a physiological role in
regulating coronary resting flow in human [11], swine [10],
dogs [45], guinea pigs [46], and mice [20, 44], while some
other groups failed to observe an endogenous role of adeno-
sine [3, 47, 48], which leaves this scientific topic controver-
sial. This discrepancy may be due to different animal models,
differences in species, and/or different agonists and antago-
nists applied in these studies [19]. However, the application of
exogenous adenosine to increase coronary flow for the inves-
tigation of adenosine receptor-mediated signaling pathways
has been well established [37, 44]. Thus, in agreement with
previous studies from our laboratory [37, 44, 49] and others
[14], adenosine produced a large increase in coronary flow in
isolated mouse hearts, supporting the overall effect of vasodi-
lation by adenosine in the coronary circulation [14, 15, 37, 50,
51].
Several recent studies showed the interaction between
adenosine and ROS via the activation of Nox, which has been
reported to be the major source of ROS in the vasculature and
involved in vascular tone regulation [27, 28]. Among Nox
isoforms, Nox2 has been extensively studied in various vas-
cular beds. Nox2 inhibition or deletion attenuated the
adenosine-mediated vasoconstriction in aortas [33] and renal
arterioles [34]. In contrast, Nox2 inhibition or ROS scaveng-
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gp91 ds-tat gp91 ds-tat
Fig. 5 Effects of Nox2 inhibition on adenosine-induced H2O2 production
in isolated coronary arteries. aRepresentative confocal fluorescence images
showing changes in DCFH-DA (dichlorofluorescin) fluorescence intensity
before (baseline) and after 5 min of adenosine (Ado) (10 μM) or 10 min of
H2O2 (200 μM) stimulation in the presence and absence of gp91 ds-tat
(1 μM) from WT, A2AAR KO, and A2BAR KO mice. Scale bar: 50 μm.
b Adenosine-induced increase in H2O2 in isolated coronary arteries of WT
(n=8), A2AAR KO (n=5), and A2BAR KOmice (n=5). Values are mean±
SEM. *P<0.05 vs. corresponding control (by paired t test)
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arteries [35] and coronary circulation [37], both of which sug-
gest that adenosine is capable of generating ROS in these
vasculatures. Consistent with our previous findings in the cor-
onary circulation but in contrast to those in other vascular beds
[33, 34, 37], Nox2 inhibition or ROS scavenging significantly
attenuated the adenosine-mediated increase in coronary flow,
suggesting that adenosine-mediated coronary vasodilation is
in part attributed to Nox2-derived ROS. This heterogeneity
might be due to vasoconstrictor ROS vs. vasodilator ROS
[29, 31] generated from different vascular beds (coronary vs.
renal artery) [34, 37]. Furthermore, in the coronary vascula-
ture, the varying effects of ROS may depend on which source
ROS are generated from (NADPH vs. uncoupled NO syn-
thase) [31, 52, 53] or the pathophysiological conditions [32,
52, 53], e.g., diabetes, and the right ventricular hypertrophy
[54–56]. In accordance with our previous studies [37], the
effect of ROS scavenging with EUK134 was comparable with
the effect of Nox2 inhibition with gp91 ds-tat in WT isolated
hearts (P=0.24), suggesting that the majority of ROS gener-
ated by adenosine is likely from Nox2, which leads to in-
creases in coronary flow. Although EUK134 is capable of
scavenging both vasoconstrictor and vasodilator ROS [57],
the observation that EUK134 significantly attenuated the
adenosine-mediated increase in coronary flow in one of our
previous studies [37] as well as in the present study suggest
that vasodilator ROS are likely generated by adenosine.
In the healthy coronary vasculature, several recent studies
addressed a crucial role of NADPH oxidase in coronary vaso-
dilation in response to various agonists. Indeed, downregula-
tion of Nox activity by cytosolic p47phox knockdown or in-
hibition of Nox2 attenuated the coronary vasodilation to vas-
cular endothelial growth factor (VEGF) [52] and bradykinin
[32], respectively. In addition, Nox2 overexpression enhanced
the coronary vasodilation in response to both VEGF and ace-
tylcholine [53], further confirming that the vasodilator ROS is
derived from Nox in this process. More importantly, Larsen
and colleagues proposed that Nox2 is a functionally relevant
source of H2O2 that mediates agonist-induced coronary vaso-
dilation [32]. In accordance with this concept, we found in the
present study as well as one of our previous studies [40] that
adenosine-increased H2O2 formation in intact isolated coro-
nary arteries was attenuated by not only Nox2 inhibition but
also catalase [40]. The production of H2O2 induced by aden-
osine might stem from the intermediate ROS product namely,
superoxide anion [27, 28, 31], as we previously reported that
adenosine is also capable of producing superoxide [37]. Thus,
it is likely that H2O2 acts as a downstream effector of super-
oxide contributing to adenosine-induced increase in coronary
flow. Regarding the source of H2O2, we believe that H2O2
produced from EC and SMC of coronary arteries may play a
major role in adenosine-mediated coronary flow. This idea is
based on our previous [40] as well as present findings that the
increased H2O2 was observed in both EC (arrow head) and
SMC (arrow) (Fig. 5a). In addition, functional A2AAR is re-
ported to be expressed on both EC and SMC [9], which is in
agreement with our previous data showing positive A2AAR
staining in both cell types of isolated mouse coronary arteries
[40]. Therefore, it is reasonable to speculate that adenosine
may act through A2AAR in both cell types producing H2O2,
and activation of A2AAR-H2O2 pathway may result in differ-
ent downstream vasodilator mechanisms, as activation of
A2AAR in different cell types of coronary artery stimulates
either cAMP-PKA or cGMP-PKG signaling [9, 12, 58, 59].
On the other hand, the cross talk of these vasodilator mecha-
nisms exists. For instance, there is a possibility that
endothelium-derived H2O2 may elicit further H2O2 produc-
tion in SMC through activation of Nox [60], independent of
A2AAR activation on SMC to activate PKG pathway, as H2O2
has been shown to be able to regulate both PKA and PKG
pathways [61]. Taken together, these findings support Nox2 as
a relevant source for H2O2 in the coronary vasculature [32]
and suggest that the involvement of Nox2-derived ROS in
adenosine-mediated coronary vasodilation is through H2O2
production.
Involvement of Nox2-derived ROS in adenosine-induced
increase in coronary flow requires the presence of A2AARs
We [9, 16] and others [14, 15] have demonstrated that
adenosine-mediated coronary vasodilation is predomi-
nantly attributed to A2AAR as compared to vasodilator
A2BAR. In contrast, adenosine A1 and A3ARs counteract
the adenosine-mediated coronary vasodilation [15, 17,
18]. Despite the findings that all four adenosine receptor
subtypes are expressed and functional in the coronary
vasculature [13], their roles in regulating coronary vascu-
lar tone through generation of ROS remain unclear. Given
the fact that Nox has been suggested to be the major
source of ROS in coronary vasculature [32, 52], it is not
clear whether this leads to the generation of ROS by aden-
osine. We recently found that activation of A3AR en-
hances Nox2-derived ROS contributing to vascular con-
traction in mouse aorta [33], suggesting a role of A3AR in
relation to ROS production. In contrast, in the coronary
circulation, we have already excluded the involvement of
A1 and A3ARs in increased flow that is coupled to the
activation of Nox2 [37].
In the present study, we further investigated the role of
adenosine A2A and A2BARs in this process. We found that
adenosine A2A but not A2BARs are required for Nox2-
mediated coronary vasodilation, as evidenced by the attenua-
tion of adenosine-increased coronary flow by Nox2 inhibition
(gp91 ds-tat) or ROS scavenging (EUK134) in both WT and
A2BAR KO mice but not in A2AAR KO mice. Furthermore,
the selective A2AAR stimulation-induced increase in coronary
flow was significantly attenuated by Nox2 inhibition in both
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WT and A2BAR KO mice, whereas Nox2 inhibition failed to
blunt the increased coronary flow upon the selective A2BAR
stimulation in WT mice. Taken together, these findings sug-
gest that A2AAR could be a potential mediator of adenosine-
induced ROS generation contributing to increases in coronary
flow. Moreover, in the isolated coronary arteries, adenosine-
increased H2O2 formation was inhibited by Nox2 blockade in
both WT and A2BAR KO mice but not in A2AAR KO mice,
further suggesting that the involvement of Nox2-derived ROS
in adenosine-induced increase in coronary flow requires the
presence of A2AAR. In contrast to coronary circulation, both
A2A and A2BARs have been observed to generate ROS ac-
counting for the vasodilation in cerebral circulation [35]. This
discrepancy may be due to the different distribution, expres-
sion, and the downstream effectors of A2A and A2BARs be-
tween these vascular beds [12, 13].
A2AAR-mediated coronary vasodilation through Nox2-
derived ROS observed in the present study may bolster
the functional influences of A2AAR by integrating the
vascular actions of the generated ROS to the previously
known A2AAR-mediated releases of other vasodilators
(such as NO [20] and prostacyclin [62]). Furthermore,
pertinent to this effect, it may also be possible that
adenosine-generated ROS is involved in mediating reac-
tive or functional hyperemia, despite the role of adenosine
in functional hyperemia remaining controversial [19].
Indeed, the involvement of adenosine in either reactive
or functional hyperemia has been shown to be mediated
by endogenously released vasodilators, including NO,
prostacyclin, and endothelium-derived hyperpolarizing
factor [38, 40, 63, 64]. The influence and interaction of
these vasoactive factors in generation of ROS by A2AAR
in the coronary circulation remain unclear. Although we
previously reported that NO and H2O2 function in a par-
allel manner contributing to the reactive hyperemia [40],
future studies focusing on this aspect will provide greater
insights into the interaction of these vasoactive factors.
Conclusions and implications
The present study shows that adenosine induces generation of
ROS (likely H2O2) through the activation of Nox2 resulting in
coronary vasodilation. This whole process requires the pres-
ence of A2AAR. These findings further support NADPH oxi-
dase as a functionally relevant source of ROS for regulating
coronary vascular tone. As both adenosine and ROS are gen-
erated and released under pathophysiological conditions [9, 65]
and generated ROS mainly exerts a detrimental influence on
the coronary vasculature [54–56], future studies addressing the
role of A2AAR in ROS-mediated coronary vascular tone regu-
lation in pathophysiological conditions will bring us greater
insights into mechanisms underlying ischemic heart disease.
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